(Total Views: 599)
Posted On: 02/23/2021 11:41:32 PM
Post# of 155577
this is my take.
We now know the Fda mhra and health Canada now have our data. They are in talks what is bad about that. Nothing at all. We will be approved soon and nothing can convince me otherwise. Every other trial had death rates in the 30+ percentile while vyrologix produced in the 22% range why was that? Standard of care was the same in all trials so what common denominator would lower those results substantially? In my estimation soc was still 30+ % but vyrologix was 15 to 18. And yes this is just my opinion.
We now know the Fda mhra and health Canada now have our data. They are in talks what is bad about that. Nothing at all. We will be approved soon and nothing can convince me otherwise. Every other trial had death rates in the 30+ percentile while vyrologix produced in the 22% range why was that? Standard of care was the same in all trials so what common denominator would lower those results substantially? In my estimation soc was still 30+ % but vyrologix was 15 to 18. And yes this is just my opinion.
(6)
(0)
